Rossana Tassi Selected Research

Hemorrhage

8/2022	Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery.
12/2020	Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes.
1/2020	Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
1/2019	Anticoagulation After Stroke in Patients With Atrial Fibrillation.
1/2018	Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy).
11/2017	Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study.
2/2016	Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study.
8/2015	Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
1/2015	Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study.
1/2014	Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rossana Tassi Research Topics

Disease

40	Stroke (Strokes) 08/2022 - 01/2012
29	Ischemic Stroke 06/2022 - 11/2011
12	Atrial Fibrillation 01/2022 - 01/2012
10	Hemorrhage 08/2022 - 01/2014
8	Cerebral Hemorrhage 10/2021 - 10/2013
3	Infarction (Infarctions) 08/2022 - 11/2011
3	Hypertension (High Blood Pressure) 10/2021 - 01/2012
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 01/2015
3	Inflammation (Inflammations) 06/2019 - 05/2016
2	Leukoaraiosis 06/2019 - 01/2019
2	Embolic Stroke 01/2019 - 08/2015
2	Heart Failure 09/2017 - 01/2012
2	Myxoma (Myxomas) 01/2014 - 11/2011
1	Blood Vessel Dissection 01/2022
1	Agnosia (Visual Agnosia) 01/2022
1	Cortical Blindness (Anton Syndrome) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2021
1	COVID-19 01/2021
1	Liver Diseases (Liver Disease) 12/2020
1	Bacterial Endocarditis 12/2020
1	Neoplasms (Cancer) 12/2020
1	Venous Thromboembolism 01/2020
1	Hematoma 01/2020
1	Pulmonary Embolism 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2019
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2019
1	Infections 09/2017
1	Atrial Remodeling 01/2017
1	Hyperhomocysteinemia 05/2016
1	Purpura 01/2015
1	Heat Stroke (Heatstroke) 08/2013
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Diabetes Mellitus 01/2012
1	Embolism (Embolus) 11/2011
1	Stomach Neoplasms (Stomach Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

12	AnticoagulantsIBA 01/2021 - 08/2015
6	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2017 - 11/2011
4	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 09/2021 - 01/2012
4	Vitamin K FDA Link 01/2021 - 11/2017
4	Metalloproteases (Metalloproteinases)IBA 01/2019 - 10/2013
3	ORALIT (ORS)IBA 08/2022 - 12/2020
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 10/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2019
2	C-Reactive ProteinIBA 06/2019 - 01/2017
2	CholesterolIBA 01/2016 - 01/2012
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2019
1	SmokeIBA 06/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2019
1	von Willebrand FactorIBA 06/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Dabigatran FDA Link 11/2017
1	apixabanIBA 11/2017
1	RivaroxabanIBA 11/2017
1	Amyloidogenic ProteinsIBA 09/2017
1	HomocysteineIBA 05/2016
1	Antihypertensive Agents (Antihypertensives)IBA 01/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2013
1	Topiramate (Topamax)FDA LinkGeneric 08/2013
1	Dihydrotachysterol (AT 10)IBA 01/2013
1	Blood Glucose (Blood Sugar)IBA 01/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2008

Therapy/Procedure

20	Thrombectomy 08/2022 - 09/2017
14	Therapeutics 01/2022 - 11/2011
5	Thrombolytic Therapy 01/2020 - 01/2012
4	Secondary Prevention 04/2022 - 02/2016
3	Mechanical Thrombolysis 01/2022 - 01/2014
2	Punctures 08/2022 - 01/2020
2	Activities of Daily Living (ADL) 01/2013 - 01/2012
1	Endovascular Procedures 05/2021
1	Conscious Sedation 01/2020
1	Local Anesthesia 01/2020
1	General Anesthesia 01/2020
1	Contraindications 05/2019
1	Catheters 05/2019
1	Operative Surgical Procedures 05/2016
1	Heart Transplantation (Grafting, Heart) 05/2016
1	Aftercare (After-Treatment) 11/2011
1	Adjuvant Chemotherapy 01/2008